Animals as sentinels of bioterrorism agents

Emerging Infectious Diseases

Volumn 12, Issue 4, 2006, Pages 647-652

  Rabinowitz, Peter ^a   Gordon, Zimra ^a,b   Chudnov, Daniel ^a   Wilcox, Matthew ^a   Odofin, Lynda ^a   Liu, Ann ^a   Dein, Joshua ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rippowam Animal Hospital   (United States)

^c NATIONAL WILDLIFE HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL DISEASE; BACTERIAL INFECTION; BIOLOGICAL WARFARE; DISEASE CONTROL; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; HEALTH SURVEY; HUMAN; NONHUMAN; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VIRUS INFECTION;

EID: 33645464373     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1204.051120     Document Type: Review

References (39)

1. Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep. 2000;49:1-14.
2. Cottrell TS, Morgan ER. Animal surveillance in NBC defensive operations. J R Army Med Corps. 2003;149:225-30.
3. Davis RG. The ABCs of bioterrorism for veterinarians, focusing on Category A agents. J Am Vet Med Assoc. 2004;224:1084-95.
4. Kortepeter M, Eitzen E Jr, Mckee K Jr, editors. USAMRIID's medical management of biological casualties handbook. 4th ed. McLean (VA): International Medical Publishing Inc; 2001.
5. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Levels of evidence and grades of recommendation. Oxford Centre for Evidence Based Medicine; 2001 [cited 2005 Nov 28]. Available from http://www.cebm.net/ levels_of_evidence.asp#levels.
6. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-8.
7. Gleiser CA, Gochenour WS Jr, Ward MK. Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores. J Comp Pathol. 1968;78:445-8.
8. McGee ED, Fritz DL, Ezzell JW, Newcomb HL, Brown RJ, Jaax NK. Anthrax in a dog. Vet Pathol. 1994;31:471-3.
9. Rust JH Jr, Cavanaugh DC, O'Shita R, Marshall JD Jr. The role of domestic animals in the epidemiology of plague. I. Experimental infection of dogs and cats. J Infect Dis. 1971;124:522-6.
10. Kilonzo BS, Mbise TJ, Makundi RH. Plague in Lushoto district, Tanzania, 1980-1988. Trans R Soc Trop Med Hyg. 1992;86:444-5.
11. Eidson M, Thilsted JP, Rollag OJ. Clinical, clinicopathologic, and pathologic features of plague in cats: 119 cases (1977-1988). J Am Vet Med Assoc.1991;199:1191-7.
12. Christie AB, Chen TH, Elberg SS. Plague in camels and goats: their role in human epidemics. J Infect Dis. 1980;141:724-6.
13. Dahlstrand S, Ringertz O, Zetterberg B. Airborne tularemia in Sweden. Scandinavian J Infect Dis. 1971;3:7-16.
14. Feldman, KA, Enscore RE, Lathrop SR, Matyas BT, McGuill M, Schriefer ME, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med. 2001;345:1601-6.
15. Avashia SB, Peterson JM, Lindley CM, Schriefer ME, Gage KL, Cetron M, et al. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg Infect Dis. 2004;10:483-6.
16. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-70. Erratum in: JAMA 2001;285:2081
17. Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Forment J, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 2004;303:387-90.
18. Martinov SP, Neikov P, Popov GV. Experimental Q fever in sheep. Eur J Epidemiol. 1989;5:428-31.
19. Clark RK, Jessup DA, Hird DW, Ruppanner R, Meyer ME. Serologic survey of California wild hogs for antibodies against selected zoonotic disease agents. J Am Vet Med Assoc. 1983;183:1248-51.
20. Scrimgeour EM, Al-Ismaily SI, Rolain JM, Al-Dhahry SH, El-Khatim HS, Raoult D. Q fever in human and livestock populations in Oman. Ann N Y Acad Sci. 2003;990:221-5.
21. McQuiston JH, Childs JE, Thompson HA. Q fever. J Am Vet Med Assoc. 2002;221:796-9.
22. Kubuafor DK, Awumbila B, Akanmori BD. Seroprevalence of brucellosis in cattle and humans in the Akwapim-South district of Ghana: public health implications. Acta Trop. 2000;76:45-8.
23. Radostits OMG, Gay CC, Blood DC, Hinchcliff KW, editors. Veterinary medicine: a textbook of the diseases of cattle, sheep, pigs, goats and horses. 9th ed. London: Harcourt Publishers Ltd; 2000.
24. Cupp OS, Walker DE 2nd, Hillison J. Agroterrorism in the U.S.: key security challenge for the 21st century. Biosecurity and Bioterrorism. 2004;2:97-105.
25. Arun S, Neubauer H, Gurel A, Ayyildiz G, Kuscu B, Yesidere T, et al. Equine glanders in Turkey. Institute for Animal Pathology. 1999;144:255-8.
26. Greene CE. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: W.B. Saunders; 1998.
27. Howard JJ, Grayson MA, White DJ, Oliver J. Evidence for multiple foci of eastern equine encephalitis virus (Togaviridae:Alphavirus) in central New York State. J Med Entomol. 1996;33:421-32.
28. Olaleye OD, Tomori O, Schmitz H. Rift Valley fever in Nigeria: infections in domestic animals. Rev Sci Tech. 1996;15:937-46.
29. Gargan TP 2nd, Clark GG, Dohm DJ, Turell MJ, Bailey CL. Vector potential of selected North American mosquito species for Rift Valley fever virus. Am J Trop Med Hyg. 1988;38:440-6.
30. Bunning M. Nipah virus outbreak in Malaysia, 1998-1999. Journal of Swine Health Products. 2001;9:295-9.
31. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol. 2002; 126:124-36.
32. Mills JN, Yates TL, Ksiazek TG, Peters CJ, Childs JE. Long-term studies of Hantavirus reservoir populations in the southwestern United States: rationale, potential, and methods. Emerg Infect Dis. 1999;5:95-101.
33. Traavik T, Sommer A, Mehl R, Berdal BP, Stavem K, Hunderi OH, et al., Nephropathia epidemica in Norway: antigen and antibodies in rodent reservoirs and antibodies in selected human populations. J Hyg (Camb). 1984;93:139-46.
34. Mostashari F, Kulldorff M, Hartman JJ, Miller JR, Kulasekera V. Dead bird clusters as an early warning system for West Nile virus activity. Emerg Infect Dis. 2003;9:641-6.
35. Komar O, Robbins MB, Klenk K, Blitvich BJ, Marlenee NL, Burkhalter KL, et al. West Nile virus transmission in resident birds, Dominican Republic. Emerg Infect Dis. 2003;9:1299-302.
36. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9:311-22.
37. Jernigan JA, Stephen DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-44.
38. Grant S, Olsen CW. Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians. Emerg Infect Dis. 1999;5:159-63.
39. Dauphin G, Zientara S, Zeller H, Murgue B. West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis. 2004;27:343-55.